SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference4 articles.
1. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants;Wang;Cell,2023
2. Immunogenicity of BA.5 bivalent mRNA vaccine boosters;Collier;N Engl J Med,2023
3. Antibody response to omicron BA.4-BA.5 bivalent booster;Wang;N Engl J Med,2023
4. Waning immunity against XBB.1·5 following bivalent mRNA boosters;Lasrado;bioRxiv,2023
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses;Human Vaccines & Immunotherapeutics;2024-08-16
2. Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study;The Lancet Microbe;2024-08
3. Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants;Journal of Infection;2024-08
4. Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster;Cell Reports Medicine;2024-08
5. Evaluation of cross‐neutralizing immunity following COVID‐19 primary series vaccination during the Omicron surge in Tanzania;Journal of Medical Virology;2024-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3